Kbc Group Nv Catalent, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Catalent, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 23,872 shares of CTLT stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,872

Previous 23,872 -0.0%

Holding current value

$1.52 Million

Previous $1.34 Million 7.75%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$53.58 - $57.02 $16,556 - $17,619	309 Added 1.31%	23,872 $1.34 Million
Q1 2024 May 08, 2024	SELL	$42.56 - $59.82 $454,796 - $639,236	-10,686 Reduced 31.2%	23,563 $1.33 Million
Q4 2023 Feb 13, 2024	SELL	$32.18 - $46.57 $561,508 - $812,599	-17,449 Reduced 33.75%	34,249 $1.54 Million
Q3 2023 Feb 15, 2024	SELL	$44.2 - $50.2 $888,420 - $1.01 Million	-20,100 Reduced 37.75%	33,152 $1.51 Million
Q2 2023 Feb 15, 2024	SELL	$31.86 - $67.26 $4.63 Million - $9.78 Million	-145,458 Reduced 73.2%	53,252 $2.31 Million
Q2 2023 Jul 28, 2023	SELL	$31.86 - $67.26 $1.5 Million - $3.17 Million	-47,202 Reduced 47.73%	51,698 $2.24 Million
Q1 2023 Feb 14, 2024	BUY	$45.44 - $74.26 $1.98 Million - $3.23 Million	43,539 Added 76.53%	100,430 $6.6 Million
Q1 2023 May 04, 2023	SELL	$45.44 - $74.26 $4.52 Million - $7.39 Million	-99,568 Reduced 50.17%	98,900 $6.5 Million
Q4 2022 Feb 14, 2024	SELL	$41.39 - $81.0 $6.04 Million - $11.8 Million	-146,046 Reduced 71.97%	56,891 $2.56 Million
Q3 2022 Feb 15, 2024	BUY	$72.36 - $113.1 $11.9 Million - $18.6 Million	164,461 Added 480.19%	198,710 $14.4 Million
Q3 2022 Nov 08, 2022	SELL	$72.36 - $113.1 $223,737 - $349,705	-3,092 Reduced 1.53%	198,468 $14.4 Million
Q2 2022 Feb 14, 2024	BUY	$87.2 - $114.05 $2.02 Million - $2.64 Million	23,164 Added 12.89%	202,937 $21.8 Million
Q2 2022 Jul 26, 2022	BUY	$87.2 - $114.05 $1.9 Million - $2.48 Million	21,787 Added 12.12%	201,560 $21.6 Million
Q1 2022 Feb 14, 2024	BUY	$94.19 - $124.49 $15.3 Million - $20.2 Million	162,242 Added 925.46%	179,773 $19.9 Million
Q1 2022 May 06, 2022	BUY	$94.19 - $124.49 $15.3 Million - $20.2 Million	162,242 Added 925.46%	179,773 $19.9 Million
Q4 2021 Feb 14, 2024	SELL	$119.57 - $139.07 $2 Million - $2.32 Million	-16,718 Reduced 48.81%	17,531 $2.24 Million
Q4 2021 Feb 03, 2022	SELL	$119.57 - $139.07 $246,792 - $287,040	-2,064 Reduced 10.53%	17,531 $2.24 Million
Q2 2021 Aug 11, 2021	SELL	$100.34 - $115.69 $250,749 - $289,109	-2,499 Reduced 11.31%	19,595 $2.12 Million
Q1 2021 Apr 26, 2021	BUY	$101.51 - $125.27 $483,796 - $597,036	4,766 Added 27.5%	22,094 $2.33 Million
Q3 2020 Oct 28, 2020	SELL	$72.74 - $92.5 $239,969 - $305,157	-3,299 Reduced 15.99%	17,328 $1.48 Million
Q2 2020 Aug 10, 2020	BUY	$48.02 - $79.04 $990,508 - $1.63 Million	20,627 New	20,627 $1.51 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account